In this episode, host Harriet Edwards is joined by Dr Katherine Bowen and Shalini Gupta to explore the transformative changes in the European Union's clinical trial landscape. The focus is on the transition from the Clinical Trials Directive (CTD) to the Clinical Trials Regulation (CTR) and its significant impact on the regulatory environment.
Join us for an insightful discussion on how the CTR is shaping the future of clinical research in Europe and the positive impact it aims to have on patients.
Fler avsnitt av Conversations in Drug Development
Visa alla avsnitt av Conversations in Drug DevelopmentConversations in Drug Development med Boyds finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
